To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Minimizing Blood Loss Using Tranexamic Acid for Proximal Femoral Nailing

Download
Share
Reprints
Cite This
About
+ Favorites
Download
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2023

Minimizing Blood Loss Using Tranexamic Acid for Proximal Femoral Nailing

Vol: 303| Issue: 2| Number:2| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

A single dose of tranexamic acid infusion is safe and effective to reduce total blood loss during proximal femoral nailing for intertrochanteric fractures: A prospective randomized study

Ulus Travma Acil Cerrahi Derg . 2022 Nov;28(11):1627-1633.

Contributing Authors:
M Ekinci M Ok M Ersin E G√ºnen E Kocazeybek Sñ S?rma M Y?lmaz

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred and ten elderly patients admitted to the emergency department with intertrochanteric femoral fractures were randomized to receive either tranexamic acid (n=55) or saline (n=55) for proximal femoral nailing. Outcomes of interest were hemoglobin levels, hematocrit, total blood volume, blood loss, transfusion rate and units, intraoperative fluid infusion, and the incidence of complication...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue